OpenVSafe by OpenVAERS
Search V-safe

2ZT-28236-03334

5 vaccinations 3 coded responses 36 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
622 / IL
Registered
2021-04-05
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-05
    Registered in v-safe
  2. 2021-04-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-05
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  5. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-12
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-19
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-26
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-26
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  15. 2021-04-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-03
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-05-10
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-17
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-31
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-07
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-26
    Survey response — 3 months, dose 2
    MedDRA: Cough, Dysphonia, Upper-airway cough syndrome — Feeling: Good
    Free text: Hoarseness in voice since 6/26/2021 and post nasal drainage with mild cough. No fever, chills or aches. Taking cough drops, drinking hot and cold non-alcoholic beverages. Scheduled to see ENT on 8/4/2021.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2021-10-25
    Survey response — 6 months, dose 2
    MedDRA: Dysphonia, Soft tissue swelling, Vocal cord dysfunction — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Soft tissue build up causing hoarseness and left vocal cord not properly working. · Healthcare visit (other): Had laryngoscopes; two CT SCANS of soft tissue (one without dye and one with dye); PET image; and mediastinoscopy to examine tissue for cancer cells. All done between 8/4/2021-9/2/2021. Did not have any hoarseness until Mid-July 2021.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-10-25
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2021-10-27
  30. 2021-12-06
    Dose 3 — Pfizer-BioNTech
  31. 2022-04-26
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  32. 2022-07-21
    Dose 4 — Pfizer-BioNTech
  33. 2022-10-15
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  34. 2022-10-18
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  35. 2022-10-19
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  36. 2022-10-20
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  37. 2022-10-21
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  38. 2022-10-22
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  39. 2022-10-31
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  40. 2022-11-05
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  41. 2022-11-13
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  42. 2022-11-19
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  43. 2022-11-26
    Survey response — day 42, dose 5
    MedDRA: Paranasal sinus hypersecretion, Pre-existing disease — Feeling: Good
    Free text: Seasonal allergies accompanied with sinus drainage. No fever, body aches or loss of taste or smell.
    MedDRA releases: 2024-11 · check-in free text available
  44. 2023-01-14
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-05Pfizer-BioNTech
22021-04-26Pfizer-BioNTech
32021-12-06Pfizer-BioNTech No
42022-07-21Pfizer-BioNTech No
52022-10-15Pfizer-BioNTech Flu

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-07-26

Symptoms: Hoarseness in voice since 6/26/2021 and post nasal drainage with mild cough. No fever, chills or aches. Taking cough drops, drinking hot and cold non-alcoholic beverages. Scheduled to see ENT on 8/4/2021.

Release 10 — 6 months, dose 2

2021-10-25

Symptoms: Soft tissue build up causing hoarseness and left vocal cord not properly working.
Healthcare visit (other): Had laryngoscopes; two CT SCANS of soft tissue (one without dye and one with dye); PET image; and mediastinoscopy to examine tissue for cancer cells. All done between 8/4/2021-9/2/2021. Did not have any hoarseness until Mid-July 2021.

Release 12 — day 42, dose 5

2022-11-26

Symptoms: Seasonal allergies accompanied with sinus drainage. No fever, body aches or loss of taste or smell.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVODysphonia · · ✓
SDCough ✓ · ✓
SDDysphonia ✓ · ✓
SDParanasal sinus hypersecretion · · ✓
SDPre-existing disease · · ✓
SDSoft tissue swelling · · ✓
SDUpper-airway cough syndrome ✓ · ✓
SDVocal cord dysfunction · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release